Search Results - "Litwin, Magdalena"
-
1
The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
Published in Journal of clinical medicine (13-11-2021)“…(1) Background: The aim of our study was to analyze the possible relationship of and gene variants with susceptibility and outcome of multiple myeloma (MM);…”
Get full text
Journal Article -
2
The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
Published in Frontiers in oncology (11-10-2019)“…Oxidative stress and systemic inflammation are closely linked with increased risk of cancer development. Tumor necrosis factor alpha (TNF-α) is one of the…”
Get full text
Journal Article -
3
ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma
Published in Frontiers in oncology (06-02-2019)“…The insertion (I allele) deletion (D allele) polymorphism of gene (rs4646994) may influence the etiopathogenesis of multiple myeloma (MM). gene is expressed in…”
Get full text
Journal Article -
4
The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development
Published in Life (Basel, Switzerland) (28-08-2021)“…Advances in genotypic technologies enable identification of possible associations between genetic variants of certain genes and increased risk of developing…”
Get full text
Journal Article -
5
Movement‐mediated community assembly and coexistence
Published in Biological reviews of the Cambridge Philosophical Society (01-08-2020)“…ABSTRACT Organismal movement is ubiquitous and facilitates important ecological mechanisms that drive community and metacommunity composition and hence…”
Get full text
Journal Article -
6
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
Published in Cancers (27-09-2023)“…Multiple myeloma (MM) is a multifactorial genetic disorder caused by interactive effects of environmental and genetic factors. The proper locus of the TP53…”
Get full text
Journal Article -
7
Association of Chromosome 17 Aneuploidy, ITP53/I Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
Published in Cancers (01-09-2023)“…The detailed role of the TP53 p.P72R (rs1042522) variant in the etiology and course of multiple myeloma (MM), as well as its association with chromosome 17…”
Get full text
Journal Article -
8
NOTCH3 T6746C and TP53 P72R Polymorphisms Are Associated with the Susceptibility to Diffuse Cutaneous Systemic Sclerosis
Published in BioMed research international (2020)“…Introduction. NOTCH pathway and TP53 protein are involved in the development of fibrosis and autoimmune disorders, respectively. The aim of this study was to…”
Get full text
Journal Article -
9
ACTN3 Genotype in Professional Sport Climbers
Published in Journal of strength and conditioning research (01-05-2018)“…ABSTRACTGinszt, M, Michalak-Wojnowska, M, Gawda, P, Wojcierowska-Litwin, M, Korszeń-Pilecka, I, Kusztelak, M, Muda, R, Filip, AA, and Majcher, P. ACTN3…”
Get full text
Journal Article -
10
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma
Published in Journal of clinical medicine (20-03-2023)“…(1) Background: Chemokines and chemokine receptors play an important role in tumor development. The aim of this study was to check the significance of and…”
Get full text
Journal Article -
11
The Relationship of ICCL5/I and ICCR1/I Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma
Published in Journal of clinical medicine (01-03-2023)“…(1) Background: Chemokines and chemokine receptors play an important role in tumor development. The aim of this study was to check the significance of CCL5 and…”
Get full text
Journal Article -
12
TP53 polymorphism in plasma cell myeloma
Published in Folia histochemica et cytobiologica (01-01-2017)“…Significant and accessible predictive factors for bortezomib treatment in plasma cell myeloma (PCM) are still lacking. TP53 codon 72 polymorphism (P72R)…”
Get full text
Journal Article